Adverum Biotechnologies Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc. | Key People and Executives

Paul B. Cleveland

Chairman

Mitchell H. Finer

Director

Eric G. Carter

Independent Director

Richard N. Spivey

Independent Director

Clarence Patrick Machado

Independent Director

Thomas F. Woiwode

Independent Director

Paul B. Cleveland

Chairman

Leone D. Patterson

President, CEO, CFO & Senior Vice President

Linda Neuman

Chief Medical Officer

Mehdi Gasmi

Chief Technology & Scientific Officer

Katherine Bock

VP-Investor Relations & Corporate Communications

Mitchell H. Finer

Director

Jennifer Cheng

Secretary, Vice President & General Counsel

Eric G. Carter

Independent Director

Richard N. Spivey

Independent Director

Clarence Patrick Machado

Independent Director

Thomas F. Woiwode

Independent Director

View Profile

Address	1035 O'Brien Drive Menlo Park California 94025 United States
Employees	-
Website	http://www.adverum.com
Updated	07/08/2019
Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitrypsin deficiency, hereditary angioedema, friedreich's ataxia, severe allergy, color vision deficiency, and juvenile x-linked retinoschisis. The company was founded by Mark S.